Application of SILCS to potassium channel hERG1 read more here.

News2022-06-08T02:20:42+00:00

Technical Sales for Drug Design Portfolio

Immediate Job Opening – 1/20/2022 Technical Sales Within Early Charm’s Drug Design Portfolio   SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio.   What we do: Early Charm creates, owns, and operates businesses that convert science into [...]

January 20th, 2022|

SilcsBio Spinout Raises $1.5 Million Investment

FOR IMMEDIATE RELEASE:   SilcsBio Spinout Raises $1.5 Million to Advance Drug Development New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research   December 2, 2021, Baltimore, MD – Rasio Therapeutics, a joint venture formed by SilcsBio and the National Foundation for [...]

December 2nd, 2021|

SilcsBio Announces Hiring of KC Song as Full Stack Developer

Song will focus on web applications development and solutions to help drive SilcsBio’s continued growth September 28, 2021, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of KC Song as Full Stack Developer. Song joins the [...]

November 30th, 2021|

SilcsBio Announces Hiring of Ankita Katiyar, PhD as Application Scientist

Katiyar will focus on fueling product and technology development for SilcsBio August 24, 2021, Baltimore, MD – – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of Ankita Katiyar, PhD as Applications Scientist focusing on product development. Katiyar – [...]

November 30th, 2021|
Go to Top